Andrea Natali Selected Research

Creatinine

11/2023	Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial.
1/2023	Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study.
1/2020	Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Natali Research Topics

Disease

49	Insulin Resistance 04/2024 - 12/2002
31	Type 2 Diabetes Mellitus (MODY) 04/2024 - 06/2004
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 03/2005
12	Atherosclerosis 12/2023 - 10/2011
11	Hypertension (High Blood Pressure) 06/2020 - 06/2004
10	Inflammation (Inflammations) 10/2023 - 03/2005
9	Hyperglycemia 01/2022 - 02/2002
8	Glucose Intolerance 04/2024 - 12/2006
8	Obesity 01/2024 - 12/2004
8	Hyperinsulinism (Hyperinsulinemia) 08/2023 - 06/2004
6	Heart Failure 11/2023 - 01/2020
4	Hypertriglyceridemia 04/2024 - 06/2004
4	Body Weight (Weight, Body) 11/2023 - 04/2017
4	Dyslipidemias (Dyslipidemia) 10/2010 - 06/2004
3	Overweight 11/2023 - 04/2006
3	Albuminuria 11/2023 - 11/2019
3	Abdominal Obesity 04/2016 - 06/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2024 - 10/2017
2	Chronic Renal Insufficiency 11/2023 - 11/2022
2	Neoplasms (Cancer) 10/2023 - 07/2015
2	Carotid Artery Diseases 01/2022 - 01/2022
2	Myocardial Infarction 01/2021 - 04/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2020 - 11/2019
2	Fatty Liver 01/2020 - 01/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016 - 12/2007
2	Neutral Lipid Storage Disease with Myopathy 09/2013 - 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024
1	Pathologic Constriction (Stenosis) 12/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Glycosuria 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Heart Diseases (Heart Disease) 12/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2022
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Atherosclerotic Plaque (Atheroma) 09/2021
1	Ischemic Stroke 01/2021
1	Atrial Fibrillation 01/2021

Drug/Important Bio-Agent (IBA)

49	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2002
33	Insulin (Novolin)FDA Link 04/2024 - 02/2002
13	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2010
11	LipidsIBA 04/2024 - 12/2002
9	HDL CholesterolIBA 03/2024 - 06/2004
9	Triglycerides (Triacylglycerol)IBA 01/2023 - 04/2007
9	C-PeptideIBA 01/2022 - 12/2006
6	Nonesterified Fatty Acids (NEFA)IBA 04/2024 - 06/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 11/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 05/2010
4	Peptides (Polypeptides)IBA 12/2023 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2006
4	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2015
4	C-Reactive ProteinIBA 07/2020 - 04/2006
4	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 06/2004
4	CholesterolIBA 01/2018 - 07/2006
3	CarbohydratesIBA 11/2023 - 01/2016
3	CreatinineIBA 11/2023 - 01/2020
3	IncretinsIBA 01/2021 - 12/2006
3	oxidized low density lipoproteinIBA 01/2021 - 04/2007
3	CytokinesIBA 07/2020 - 04/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012 - 06/2004
2	Oxygen (Dioxygen)IBA 01/2024 - 12/2022
2	Glucagon (Glukagon)FDA Link 11/2023 - 01/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2021
2	prostaglandin-inositol cyclic phosphateIBA 10/2023 - 09/2021
2	AdipokinesIBA 08/2023 - 06/2013
2	Uric Acid (Urate)IBA 12/2022 - 11/2008
2	empagliflozinIBA 12/2022 - 10/2017
2	Sitagliptin Phosphate (Januvia)FDA Link 12/2022 - 10/2017
2	lixisenatideIBA 01/2021 - 01/2020
2	Hormones (Hormone)IBA 01/2021 - 12/2006
2	AdiponectinIBA 01/2021 - 12/2013
2	ApolipoproteinsIBA 01/2021 - 12/2013
2	Apolipoprotein C-IIIIBA 01/2021 - 01/2018
2	Clostridium perfringens epsilon-toxinIBA 01/2020 - 01/2020
2	InterleukinsIBA 10/2019 - 04/2006
2	Matrix Metalloproteinases (MMPs)IBA 10/2019 - 07/2015
2	Amino Acids FDA Link 09/2019 - 05/2010
2	LigandsIBA 10/2018 - 11/2006
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018 - 10/2011
2	Lipase (Acid Lipase)FDA Link 09/2013 - 01/2013
2	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2006 - 06/2004
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 04/2006 - 06/2004
1	Collagen Type III (Type III Collagen)IBA 12/2023
1	Complement C3 (C3 Complement)IBA 12/2023
1	KetonesIBA 11/2023
1	CanagliflozinIBA 11/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2023
1	LeptinIBA 08/2023
1	Protons (Proton)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 12/2022
1	NAD (NADH)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	FollistatinIBA 11/2021
1	CD40 Ligand (CD40L)IBA 09/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	DiureticsIBA 01/2021

Therapy/Procedure

3	Therapeutics 10/2023 - 12/2002
2	Glycemic Control 04/2006 - 06/2004